UnicoCell Biomed Co., Ltd. (TPE:6794)
Taiwan · Delayed Price · Currency is TWD 79.40
+0.60 (0.76%)
Jun 18, 2026, 1:30 PM CST
UnicoCell Biomed Market Cap
UnicoCell Biomed has a market cap or net worth of 5.05 billion as of June 18, 2026. Its market cap has increased by 30.05% in one year.
Market Cap
5.05B
Enterprise Value
4.39B
Revenue
26.54M
Ranking
n/a
PE Ratio
n/a
Stock Price
79.40
Market Cap Chart
Since December 25, 2020, UnicoCell Biomed's market cap has increased from 1.73B to 5.05B, an increase of 192.42%. That is a compound annual growth rate of 21.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 5.05B | -7.06% |
| Dec 31, 2025 | 5.44B | 36.28% |
| Dec 31, 2024 | 3.99B | -13.33% |
| Dec 29, 2023 | 4.60B | 239.58% |
| Dec 30, 2022 | 1.36B | -17.13% |
| Dec 30, 2021 | 1.64B | 1.26% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 25, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TaiGen Biopharmaceuticals Holdings | 6.22B |
| Savior Lifetec | 6.19B |
| Sinphar Pharmaceutical | 6.07B |
| Steminent Biotherapeutics | 5.58B |
| AnnJi Pharmaceutical | 5.57B |
| TWi Biotechnology | 5.45B |
| Mycenax Biotech | 5.22B |
| Panion & Bf Biotech | 5.14B |